ARCHIVES

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

NTP Board Okays Contract Concepts

July 10, 1981

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

NIH To Give 3 Percent Increase to Grants

March 20, 2009

RFA: Native American Women’s Cancer Initiative

July 9, 1993